Document is current
Any future updates will be listed below
-
Authors
Janes, Holly
Fong, Youyi
Huang, Ying
Benkeser, David
Kelly, Elizabeth J.
Hirsch, Ian
Stanley, Ann Marie
Villafana, Tonya
Petropoulos, Christos J.
Leith, Andrew
Haugaard, Deanne
Webb, Bill
Lu, Yiwen
Yu, Chenchen
Borate, Bhavesh
van der Laan, Lars W. P.
Hejazi, Nima S.
Randhawa, April K.
Andrasik, Michele P.
Kublin, James G.
Isaacs, Margaret Brewinski
Makhene, Mamodikoe
Tong, Tina
Robb, Merlin L.
Corey, Lawrence
Neuzil, Kathleen M.
Follmann, Dean
Falsey, Ann R.
Sobieszczyk, Magdalena E.
Koup, Richard A.
Gilbert, Peter B.
,
,
,
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (UM1 AI68614)
National Institute of Allergy and Infectious Diseases (UM1 AI68635)
- License Information
-
More Information
Article History
Received: 26 June 2024
Accepted: 22 February 2026
First Online: 18 April 2026
Competing interests
: E.J.K., I.H., A.M.S., and T.V. are/were employees of AstraZeneca and hold/may hold stock in AstraZeneca. K.M.N. is an Editorial Board Member of npj Vaccines. She was not involved in the journal’s review of, or decisions related to, this manuscript. All other authors declare no competing interests.
